Promising eye drug trial halted early – only 16 patients enrolled
Disease control
Terminated
This study tested whether the drug aflibercept could reduce swelling in the retina caused by a rare eye condition called macular telangiectasia type 1. The trial planned to compare aflibercept to a placebo over six months, but it was stopped early and only enrolled 16 people. Bec…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Apr 30, 2026 15:49 UTC